bioAffinity Technologies, Inc. 8-K

What Happened
bioAffinity Technologies, Inc. filed a Form 8-K reporting that on March 5, 2026 directors Robert Anderson and Roby Joyce informed the Board they will not stand for re-election when their terms expire at the Company’s 2026 Annual Meeting of Stockholders, currently scheduled for April 30, 2026. The company stated their decisions were not due to any disagreements with the company’s operations, policies or practices.

Key Details

• Filing: Form 8-K filed March 6, 2026 (reports action dated March 5, 2026).
• Directors: Robert Anderson and Roby Joyce will not stand for re-election.
• Timing: Their current terms expire at the Annual Meeting scheduled for April 30, 2026.
• Reason: Neither director’s decision resulted from any disagreement with the company on operations, policies or practices (as disclosed).

Why It Matters
Board departures can change governance and oversight dynamics; investors should note upcoming changes to board composition ahead of the April 30, 2026 annual meeting. The 8-K does not announce replacements or any operational issues, but shareholders may watch proxy materials and company announcements for nominee information or further governance updates.